- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Sight Sciences Inc (SGHT)
Assess today's live Sight Sciences Inc (SGHT) share price, performance and insights using our live NASDAQ: SGHT stock exchange data.
Analyse the historical data and Sight Sciences Inc share price performance charts on this page. Our technical summary section provides analysis on Sight Sciences share price buy/sell indicators using real-time data (or discuss the Sight Sciences (SGHT) stock price today with other investors in the Sight Sciences NASDAQ share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current NASDAQ SGHT share price (ISIN: US82657M1053) to enhance your trading decisions with our free investment tools and resources.
What Is the Sight Sciences Inc Share Price Today?
The Sight Sciences share price today is 4.01.
What Is the Stock Symbol for Sight Sciences Inc
The stock symbol (or 'ticker') for Sight Sciences Inc is "SGHT."
What Stock Exchange Does Sight Sciences Inc Trade On?
Sight Sciences Inc is listed and trades on the NASDAQ stock exchange.
Is Sight Sciences Inc a Good Stock to Buy?
Determining whether Sight Sciences Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
Analyse the historical data and Sight Sciences Inc share price performance charts on this page. Our technical summary section provides analysis on Sight Sciences share price buy/sell indicators using real-time data (or discuss the Sight Sciences (SGHT) stock price today with other investors in the Sight Sciences NASDAQ share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current NASDAQ SGHT share price (ISIN: US82657M1053) to enhance your trading decisions with our free investment tools and resources.
What Is the Sight Sciences Inc Share Price Today?
The Sight Sciences share price today is 4.01.
What Is the Stock Symbol for Sight Sciences Inc
The stock symbol (or 'ticker') for Sight Sciences Inc is "SGHT."
What Stock Exchange Does Sight Sciences Inc Trade On?
Sight Sciences Inc is listed and trades on the NASDAQ stock exchange.
Is Sight Sciences Inc a Good Stock to Buy?
Determining whether Sight Sciences Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
NASDAQ
Currency in USD
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
3.97
4.27
52 wk Range
2.03
9.24
SGHT is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
3.974.27
52 wk Range
2.039.24
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
SGHT Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Price Target
9.25
Upside
+130.67%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
2 analysts have revised their earnings upwards for the upcoming period
- Form 8K Sight Sciences Inc For: 4 March
- Investing.com
- Sight Sciences receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Sight Sciences receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- Sight Sciences receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Sight Sciences receives Investment Bank Analyst Rating Update
- Investing.com
Pro
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Sell
Moving Averages
Strong Sell
Sight Sciences, Inc., an ophthalmic medical device company, focuses on the development and commercialization of surgical and nonsurgical technologies for the treatment of eye prevalent diseases in the United States. The company operates in two segments, Surgical Glaucoma and Dry Eye. It offers OMNI, a surgical system family of products, such as OMNI Ergo for the catheterization and transluminal viscodilation of Schlemm’s canal and cutting of the trabecular meshwork to reduce intraocular pressure in adult patients with open-angle glaucoma; and OMNI EDGE, an implant-free and minimally invasive glaucoma surgery technology. The company also provides SION, a bladeless and manually operated device used in ophthalmic surgical procedures to excise trabecular meshwork; and TearCare system, a proprietary, interventional, dry eye device designed to melt and facilitate the comprehensive removal of meibomian gland obstructions and restore gland functionality and healthy oil production for adult patients with evaporative dry eye disease due to meibomian gland disease when used in conjunction with manual expression of the meibomian glands for ophthalmologists and optometrists. It serves hospitals, medical centers, and eyecare professionals through sales representatives and distributors. The company was incorporated in 2010 and is headquartered in Menlo Park, California.
Sight Sciences Inc Earnings Call Summary for Q4/2025
- Sight Sciences Q4 2025 EPS of -$0.08 beat forecast of -$0.15 by 47%; revenue rose 7% YoY to $20.4M, exceeding estimates of $20.17M
- Operating expenses dropped 25% to $21.5M through cost management; gross margin held steady at 87% with net loss significantly reduced YoY
- Stock climbed 2.85% to $5.26 in after-hours trading; shares up 113% over past year despite 34% YTD decline from $9.24 52-week high
- Q1 2026 guidance projects EPS of -$0.18 with revenue of $19.36M; company targets cash flow breakeven amid continued operational efficiency focus
- CEO cited disciplined cost management positioning firm for growth; risks include supply chain disruptions and potential market saturation concerns
Last Updated: 04/03/2026, 22:28
Read Full TranscriptCompare SGHT to Peers and Sector
Metrics to compare | SGHT | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipSGHTPeersSector | |
|---|---|---|---|---|
P/E Ratio | −5.6x | −5.5x | −0.5x | |
PEG Ratio | −0.20 | 0.06 | 0.00 | |
Price/Book | 3.4x | 4.2x | 2.6x | |
Price / LTM Sales | 2.8x | 3.0x | 3.2x | |
Upside (Analyst Target) | 107.8% | 41.0% | 50.1% | |
Fair Value Upside | Unlock | 10.7% | 6.5% | Unlock |
Analyst Ratings
5 Buy
3 Hold
0 Sell
Ratings:
8 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 9.25
(+130.67% Upside)
Earnings
Latest Release
Mar 04, 2026
EPS / Forecast
-0.08 / -0.15
Revenue / Forecast
20.40M / 20.17M
People Also Watch
FAQ
What Is the Sight Sciences (SGHT) Share Price Today?
The Sight Sciences stock price today is 4.01 USD.
What Stock Exchange Does Sight Sciences (SGHT) Trade On?
Sight Sciences is listed and trades on the Nasdaq Stock Exchange.
What Is the Ticker (Stock Symbol) for Sight Sciences?
The stock symbol (also called a 'ticker') for Sight Sciences is "SGHT."
What Is the Current Sight Sciences Market Cap?
As of today, Sight Sciences market cap is 216.56M USD.
What Is Sight Sciences's (SGHT) Earnings Per Share (TTM)?
The Sight Sciences EPS is currently -0.74 (Trailing Twelve Months).
When Is the Next Sight Sciences Earnings Date?
Sight Sciences's next earnings report will be released on 13/05/2026.
Is SGHT a Buy or Sell From a Technical Analyst Perspective?
Based on today's Sight Sciences moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Sight Sciences Stock Split?
Sight Sciences has split 0 times. (See the SGHT stock split history page for full effective split date and price information.)
How Many Employees Does Sight Sciences Have?
Sight Sciences has 186 employees.
What is the current trading status of Sight Sciences (SGHT)?
As of 11/03/2026, Sight Sciences (SGHT) is trading at a price of 4.01 USD, with a previous close of 4.09 USD. The stock has fluctuated within a day range of 3.97 USD to 4.27 USD, while its 52-week range spans from 2.03 USD to 9.24 USD.
What Is Sight Sciences (SGHT) Price Target According to Analysts?
The average 12-month price target for Sight Sciences is 9.25 USD, with a high estimate of 12 USD and a low estimate of 6.5 USD. 5 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an +130.67% Upside potential.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.